MHRA, FDA to boost ventilator supply


Considering the increase in the coronavirus cases (COVID-19) in the U.S., the regulators such as the Medical and Healthcare product Regulatory Agency (MHRA) of the U.K. and the Food and Drug Administration (FDA) of the U.S. are facing supply issues in the ventilators and have measured shortages to fulfill its requirements.

Responding to the shortages to meet the growing demand, the FDA has come up with certain modifications that can be allowed to the devices and their use, which also include changes in the design to reduce aerosolization, alternate parts of materials and software changes.